Trianect has recently secured a €1.35 million investment from XO Ventures and CbusineZ! This capital injection will accelerate the development and market launch of StrokePointer™, a portable device designed to assess stroke severity directly in ambulances, enabling earlier and more informed treatment decisions that can dramatically improve patient outcomes. Congrats Wouter Potters and Henk Marquering.